Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 18,050 KRW
Change Today +300.00 / 1.69%
Volume 420.1K
038070 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 12:42 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

seoulin bioscience co ltd (038070) Snapshot

Open
18,250
Previous Close
17,750
Day High
18,850
Day Low
17,600
52 Week High
07/24/15 - 28,300
52 Week Low
09/4/14 - 7,497
Market Cap
102.4B
Average Volume 10 Days
493.1K
EPS TTM
407.27
Shares Outstanding
5.7M
EX-Date
12/29/14
P/E TM
44.3x
Dividend
122.91
Dividend Yield
0.68%
Current Stock Chart for SEOULIN BIOSCIENCE CO LTD (038070)

Related News

No related news articles were found.

seoulin bioscience co ltd (038070) Related Businessweek News

No Related Businessweek News Found

seoulin bioscience co ltd (038070) Details

Seoulin Bioscience Co., Ltd., a biotech company, provides solutions in life sciences in South Korea. The company offers VisuFect 100, an organic compound for transfection of various cells; and LentiSure that can be used for producing stable cell line and primary cell for transfer gene, brain neuron cell, stem cell, iPS cell producing, etc., as well as MyLab services. Its products and services are used in various applications, such as bioioproces production, cell biology, genomics research, and protein research. The company was founded in 1984 and is based in Seongnam, South Korea.

Founded in 1984

seoulin bioscience co ltd (038070) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

seoulin bioscience co ltd (038070) Key Developments

SeouLin Bioscience Co., Ltd. to Distribute Cellular Dynamics International, Inc.'s Products in Korea

Cellular Dynamics International, Inc. announced an exclusive agreement with SeouLin Bioscience Co. Ltd., for the distribution of CDI's products in the Republic of Korea. Under the terms of the agreement, SeouLin Bioscience will distribute CDI's iCell® catalog of products. CDI's iCell products are human induced pluripotent stem cell (iPSC)-derived tissue cells, including cardiomyocytes, hepatocytes, and neurons, among others totaling up to 12 cell types, as well as special media if required. Under discussion is the expansion to distribute the MyCell® catalog of products. CDI's MyCell Products enable researchers to better understand the phenotypic underpinnings of a disease of interest, as they submit donor samples to CDI for the manufacture of iPSCs and tissue cells from them. In addition, MyCell Products are already available for diseases such as cardiac arrhythmias, Alzheimer's and Parkinson's diseases, drug-induced liver injury, and muscular dystrophies. As part of the agreement, SeouLin Bioscience will handle first-level technical support inquiries from its customers.

Seoulinbioscience Co. Ltd., Annual General Meeting, Mar 17, 2015

Seoulinbioscience Co. Ltd., Annual General Meeting, Mar 17, 2015., at 09:00 Korea Standard Time. Location: Bundang Korea Bio Park, Building A, 4th Floor (Headquarters Conference Room). Agenda: To consider approval of financial statements (including cash and stock dividends); to consider appointment of directors; and to consider approval of remuneration.

Seoulinbioscience Co. Ltd., Annual General Meeting, Mar 21, 2014

Seoulinbioscience Co. Ltd., Annual General Meeting, Mar 21, 2014., at 09:00 Korea Standard Time. Location: Bundang Korea Bio Park, Building A, 4th Floor (Headquarters Conference Room). Agenda: To consider the approval of financial statements (including cash and stock dividends); to approve the appointment of outside Directors; to approve the appointment of Audit; to approve the director remuneration; and to approve the other references concerning investment decisions.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
038070:KS 18,050.00 KRW +300.00

038070 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 038070.
View Industry Companies
 

Industry Analysis

038070

Industry Average

Valuation 038070 Industry Range
Price/Earnings 40.4x
Price/Sales 2.4x
Price/Book 2.1x
Price/Cash Flow 31.2x
TEV/Sales 1.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEOULIN BIOSCIENCE CO LTD, please visit www.seoulin.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.